Remarkably, increased UBE2C expression promotes chromosomal instability, cell cycle progression, proliferation and EMT, being positively correlated with worse clinical outcomes, mainly overall survival, lymph node metastasis, and progression-free survival. Here, UBE2C is linked to metastatic malignant neoplasm in the lymph nodes.